Lehigh Valley Health Network

LVHN Scholarly Works
Patient Care Services / Nursing

Urinary Retention in Postoperative Patients with
Scopolamine Patches
Jamie Apa BSN, RN
Lehigh Valley Health Network, Jamie.Apa@lvhn.org

Erin Hill BSN, RN
Lehigh Valley Health Network, Erin.Hill@lvhn.org

Michaela Strunk ADN, RN
Lehigh Valley Health Network, Michaela.Strunk@lvhn.org

Follow this and additional works at: https://scholarlyworks.lvhn.org/patient-care-services-nursing
Published In/Presented At
Apa, J. Hill, E. Strunk, M. (2018, August 2). Urinary Retention in Postoperative Patients with Scopolamine Patches. Poster presented at:
LVHN Vizient/AACN Nurse Residency Program Graduation, Lehigh Valley Health Network, Allentown, PA

This Poster is brought to you for free and open access by LVHN Scholarly Works. It has been accepted for inclusion in LVHN Scholarly Works by an
authorized administrator. For more information, please contact LibraryServices@lvhn.org.

Urinary Retention in Postoperative Patients with Scopolamine Patches
Jamie Apa, BSN, RN; Erin Hill, BSN, RN; Michaela Strunk, ADN, RN
Lehigh Valley Health Network, Allentown, Pennsylvania

Background
4KS patients with a scopolamine patch were
experiencing increased length of stay related to urinary
retention.
• Scopolamine
– An anti-cholinergic often used to prevent postoperative nausea
– Urinary retention is a known potential side effect
• LVHN Urinary Retention Policy
– Patients have 8 – 10 hours to spontaneously void
after Foley catheter removal
– If unable to void spontaneously, the patient is straight
catheterized
– After three straight catheterizations 6-8 hours apart, a
Foley catheter is placed
• Each time a patient is catheterized, they are made
susceptible to infection

PICO
• In postoperative patients, how does the use of
scopolamine patches compared to no scopolamine
patches affect urinary retention?
– P: postoperative patients
– I: removal of scopolamine patch after first
catheterization
– C: no patch
– O: decreased urinary retention

Implementation
• Nursing staff was educated in person at huddles and
electronically on the protocol and was involved in
collecting pre-data and post-data
• Patients who experienced urinary retention while
wearing a scopolamine patch were recorded
• For post-data collection, an order was obtained from
the provider to remove the scopolamine patch after 8
hours of urinary retention in hopes of eliminating the
need for further catheterizations

Outcomes
Only one patient had experienced post-operative urinary
retention while wearing a scopolamine patch. The patient
was catheterized once and the patch was then removed
15 hours post-operatively. The patient was then able to
urinate spontaneously and avoid any additional
catheterizations. Patient had orders received for
removal 5 hours after catheterization.

• Data was reviewed for effectiveness of intervention

Pre-data
Sample size of patients was 55. 10/55 experienced
urinary retention

Barriers
• Limited sample size for post-data
• Fewer patches were used perioperatively
during post-data collection
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Evidence
• Higher perioperative exposure to anti-cholinergic
medications significantly increases the risk of failed
postoperative voiding (Walter, Dieter, Siddiqui,
Weidner, & Wu, 2014)
• Transdermal scopolamine is not a risk factor for acute
postoperative urinary retention after pelvic
reconstructive procedures (Propst, O'Sullivan, &
Tulikangas, 2016)
• In the present large cohort of general surgical patients,
the prevalence of post-operative urinary retention was
approximately 5%. (Dreijer, Moller, & Bartholdy, 2011)
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